NAYA Biosciences announces research alliance with ONK Therapeutics
The partnership will explore the synergy between NAYA's GPC3-targeted NY-303 FLEX-NK bispecific antibody and ONK's ONKT105 - an…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Dec 23
The partnership will explore the synergy between NAYA's GPC3-targeted NY-303 FLEX-NK bispecific antibody and ONK's ONKT105 - an…
07 Dec 23
The approval was based on the interim analysis of 386 patients in the Phase 3 KarMMa-3 study in…
07 Dec 23
IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024
06 Dec 23
The research collaboration will leverage BigHat’s artificial intelligence and machine learning (AI/ML) guided Milliner platform and AbbVie’s expertise…
06 Dec 23
Under the terms of this arrangement, the French pharmatech firm will use its deep physics and generative AI…
06 Dec 23
A comparison of the intent-to-treat population at eight years of follow-up with MONARCH 3 revealed that women taking…
06 Dec 23
The trial achieved progression-free survival (PFS) and showed a statistically significant and clinically meaningful improvement against palbociclib and…
06 Dec 23
The expansion marks a continuation of the established partnership between Oxford and Ionis, which began with Oxford's acquisition…
06 Dec 23
Financing led by Ascenta Capital with participation from new and existing investors; Dr. Lorence Kim joins board of…
05 Dec 23
Through the acquisition, Roche will get access to Carmot’s portfolio of incretins, including its lead asset CT-388, along…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates